Intense Multifactorial Treatment for Type 2 Diabetes Shown to Be Cost Effective
June 25, 2018
June 25, 2018
ORLANDO, Florida, June 25 -- The American Diabetes Association issued the following news release:
When patients with type 2 diabetes (T2D) receive intensified, multifactorial treatment combining lifestyle modification and pharmacological therapy for modifiable risk factors, there is no significant increase in medical costs, compared to patients who receive conventional, multifactorial treatment, according to the study, "A Cost Analysis of Intensified vs. Conventional Multifacto . . .
When patients with type 2 diabetes (T2D) receive intensified, multifactorial treatment combining lifestyle modification and pharmacological therapy for modifiable risk factors, there is no significant increase in medical costs, compared to patients who receive conventional, multifactorial treatment, according to the study, "A Cost Analysis of Intensified vs. Conventional Multifacto . . .